A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Genzada Pharmaceuticals USA, Inc.
Sorrento Therapeutics, Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)